Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > REGULATORY
REGULATORY
- Drug Makers, Distributors Rolling Up Their Sleeves for Mandatory Barcode Labeling
February 26, 2016
- MHLW Grants Orphan Designation to Takeda’s MM Drug Ixazomib
February 26, 2016
- MHLW Panel Backs Approval of Sanofi’s Antiepileptic Drug, OKs Cymbalta’s New Indication by Unanimous Vote
February 25, 2016
- Industry Must Find Logical Reasons to Dodge Re-Pricing amid Growing Pressure on Huge Sellers
February 24, 2016
- Possible Price Slash for Big-Sellers Looms as 2017 Tax Hike Nears; All Eyes on Opdivo
February 24, 2016
- MHLW Taskforce on Vaccines and Blood Products Holds 2nd Meeting
February 23, 2016
- Pricing Debate Spills Over into MHLW Safety Panel, Member Warns Opdivo Costs Could Jeopardize State Finances
February 22, 2016
- Next Invitation for Sakigake Pathway Might Not Happen Until FY2017, Designations Likely to Decrease: Official
February 18, 2016
- Terms of Emergency Deliveries Emerge as New Challenge amid Growing Generic Use
February 17, 2016
- Add Rhabdomyolysis to Nexium Label: MHLW
February 17, 2016
- LDP Lawmaker Questions “Huge Seller” Re-Pricing
February 17, 2016
- Cause of Post-HPV Vaccine Symptoms Can’t Be Immediately Elucidated: Govt
February 16, 2016
- 22 Firms Win Approvals for Zyprexa Generics for June Listing; Kipres AGs Also OK’ed
February 16, 2016
- MHLW to Hold Supplementary Review on Cymbalta’s New Pain Indication
February 16, 2016
- MHLW Panel to Discuss Sanofi’s Antiepileptic Drug Vigabatrin on Feb. 24
February 16, 2016
- MHLW Advisory Committee to Discuss 2 Lung Cancer Drugs on Feb. 26
February 16, 2016
- 3 Regenerative Medicine Products, 2 Medical Devices Designated for Sakigake Review: MHLW
February 15, 2016
- Chuikyo OKs Basic Plan for Pilot-Based HTA Scheme; Sovaldi, Opdivo Emerge as Likely Candidates
February 12, 2016
- Chuikyo Submits Recommendation for FY2016 Reimbursement Policy Reform, New Generic Incentive for Clinics Already Questioned
February 12, 2016
- Working Group Debate Kicks Off toward Realizing New Ryukaikon Proposal
February 12, 2016
ページ
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Adeno-associated virus (AAV) gene therapies have long been viewed as carrying only a minimal risk of insertional mutagenesis — a…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…